114 related articles for article (PubMed ID: 7493372)
1. Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatment.
Murray JL; Macey DJ; Grant EJ; Rosenblum MG; Kasi LP; Zhang HZ; Katz RL; Riger PT; LeBherz D; Bhadkamkar V
Cancer Res; 1995 Dec; 55(23 Suppl):5925s-5928s. PubMed ID: 7493372
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
Macey DJ; Grant EJ; Kasi L; Rosenblum MG; Zhang HZ; Katz RL; Rieger PT; LeBherz D; South M; Greiner JW; Schlom J; Podoloff DA; Murray JL
Clin Cancer Res; 1997 Sep; 3(9):1547-55. PubMed ID: 9815842
[TBL] [Abstract][Full Text] [Related]
3. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer.
Meredith RF; Khazaeli MB; Macey DJ; Grizzle WE; Mayo M; Schlom J; Russell CD; LoBuglio AF
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3254s-3258s. PubMed ID: 10541372
[TBL] [Abstract][Full Text] [Related]
5. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
6. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen.
Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Mariani-Costantini R; Greiner JW; Casciani CU; Schlom J
J Clin Oncol; 1996 Jul; 14(7):2031-42. PubMed ID: 8683233
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
Slovin SF; Scher HI; Divgi CR; Reuter V; Sgouros G; Moore M; Weingard K; Pettengall R; Imbriaco M; El-Shirbiny A; Finn R; Bronstein J; Brett C; Milenic D; Dnistrian A; Shapiro L; Schlom J; Larson SM
Clin Cancer Res; 1998 Mar; 4(3):643-51. PubMed ID: 9533532
[TBL] [Abstract][Full Text] [Related]
9. Phase II radioimmunotherapy trial with 131I-CC49 in colorectal cancer.
Murray JL; Macey DJ; Kasi LP; Rieger P; Cunningham J; Bhadkamkar V; Zhang HZ; Schlom J; Rosenblum MG; Podoloff DA
Cancer; 1994 Feb; 73(3 Suppl):1057-66. PubMed ID: 8306248
[TBL] [Abstract][Full Text] [Related]
10. High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.
Tempero M; Leichner P; Baranowska-Kortylewicz J; Harrison K; Augustine S; Schlom J; Anderson J; Wisecarver J; Colcher D
Clin Cancer Res; 2000 Aug; 6(8):3095-102. PubMed ID: 10955789
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
[TBL] [Abstract][Full Text] [Related]
12. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
Nieroda CA; Milenic DE; Carrasquillo JA; Scholm J; Greiner JW
Cancer Res; 1995 Jul; 55(13):2858-65. PubMed ID: 7796413
[TBL] [Abstract][Full Text] [Related]
13. Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated Fab fragments of the TAG-72 monoclonal antibody CC49.
Tang Y; Yang S; Gariépy J; Scollard DA; Reilly RM
Bioconjug Chem; 2007; 18(3):677-84. PubMed ID: 17361988
[TBL] [Abstract][Full Text] [Related]
14. High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial.
Tempero M; Leichner P; Dalrymple G; Harrison K; Augustine S; Schlam J; Anderson J; Wisecarver J; Colcher D
J Clin Oncol; 1997 Apr; 15(4):1518-28. PubMed ID: 9193348
[TBL] [Abstract][Full Text] [Related]
15. Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.
Divgi CR; Scott AM; Dantis L; Capitelli P; Siler K; Hilton S; Finn RD; Kemeny N; Kelsen D; Kostakoglu L
J Nucl Med; 1995 Apr; 36(4):586-92. PubMed ID: 7699446
[TBL] [Abstract][Full Text] [Related]
16. Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49.
Kostakoglu L; Divgi CR; Hilton S; Cordon-Cardo C; Scott AM; Kalaigian H; Finn RD; Schlom J; Larson SM
Cancer Invest; 1994; 12(6):551-8. PubMed ID: 7994589
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
Mulligan T; Carrasquillo JA; Chung Y; Milenic DE; Schlom J; Feuerstein I; Paik C; Perentesis P; Reynolds J; Curt G
Clin Cancer Res; 1995 Dec; 1(12):1447-54. PubMed ID: 9815943
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.
Zou P; Xu S; Povoski SP; Wang A; Johnson MA; Martin EW; Subramaniam V; Xu R; Sun D
Mol Pharm; 2009; 6(2):428-40. PubMed ID: 19718796
[TBL] [Abstract][Full Text] [Related]
19. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
DePalatis LR; Johnson KA; Kaplan DA
Lab Invest; 1991 Jul; 65(1):111-20. PubMed ID: 2072661
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
Pavlinkova G; Booth BJ; Batra SK; Colcher D
Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
